Chang Gung University College of Medicine Researchers Provide New Study Findings on Information Technology (Prescription characteristics of Xue-Fu-Zhu-Yu-Tang in pain management: a population-based study using the National Health Insurance …): Information Technology

2023 DEC 07 (NewsRx) -- By a News Reporter-Staff News Editor at Information Technology Business Daily -- Investigators publish new report on information technology. According to news originating from Kaohsiung City, Taiwan, by NewsRx correspondents, research stated, “To explore the prevalence and distinctive features of Xue-Fu-Zhu-Yu-Tang (XFZYT) prescriptions by analyzing the National Health Insurance Research Database (NHIRD) to identify the specific medical problems for which XFZYT is prescribed.”

Our news correspondents obtained a quote from the research from Chang Gung University College of Medicine: “This nationwide, population-based, cross-sectional study included 109,073 XFZYT users and 532,848 XFZYT non-users among Chinese herbal product (CHP) users in NHIRD. Chi-squared tests were used to analyze disparities between the XFZYT user and XFZYT non-user cohorts, and the mean age was evaluated using the Wilcoxon rank-sum test. Logistic regression was used to compute the odds ratios (ORs) and 95% confidence intervals (95% CIs). XFZYT was frequently used to treat pain. The top five conditions for which the Taiwanese traditional Chinese medicine (TCM) practitioners would prescribe XFZYT were chest pain; headache; myalgia and myositis; lumbago; and neuralgia, neuritis, and radiculitis.”

According to the news reporters, the research concluded: “This study represents an inaugural comprehensive survey conducted on the utilization of XFZYT prescriptions among patients with diverse diseases. XFZYT is mostly used to treat pain conditions in Taiwan. Combined with the combination use of other CHPs, XFZYT is used to treat symptoms of the chest and respiratory system, soft tissue conditions, menstruation disorders, and joint and back discomfort. These results suggest that further clinical trials are warranted to verify the effects of XFZYT in pain management.”

For more information on this research see: Prescription characteristics of Xue-Fu-Zhu-Yu-Tang in pain management: a population-based study using the National Health Insurance Research Database in Taiwan. Frontiers in Pharmacology, 2023,14. (Frontiers in Pharmacology - http://journal.frontiersin.org/journal/pharmacology). The publisher for Frontiers in Pharmacology is Frontiers Media S.A.

A free version of this journal article is available at https://doi.org/10.3389/fphar.2023.1233156.

Our news editors report that more information may be obtained by contacting Chun-En Kuo, Department of Chinese Medicine, Kaohsiung Chang Gung Memorial Hospital and School of Traditional Chinese Medicine, Chang Gung University College of Medicine, Kaohsiung, Taiwan. Additional authors for this research include Sheng-Feng Hsu, Ching-Chih Chen, Szu-Ying Wu, Yu-Chiang Hung, Chung Y. Hsu, I.-Ju Tsai, Wen-Long Hu.

(Our reports deliver fact-based news of research and discoveries from around the world.)